+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Computer-aided Detection for Breast Cancer Screening Market - Global Forecast 2025-2030- Product Image
Computer-aided Detection for Breast Cancer Screening Market - Global Forecast 2025-2030- Product Image
Sale

Computer-aided Detection for Breast Cancer Screening Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6152350
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Leveraging AI-driven detection to revolutionize breast cancer screening by improving diagnostic accuracy and accelerating clinical workflow efficiency

The rapid evolution of artificial intelligence and imaging technology has ushered in a new era for breast cancer screening, where computer-aided detection is no longer a futuristic concept but an integral part of routine clinical workflows. As healthcare providers face growing demands to enhance diagnostic precision while managing increasing patient volumes, AI-driven CAD systems have emerged as critical tools for early lesion identification and risk stratification.

In this context, the intersection of deep learning algorithms with advanced imaging modalities has fundamentally altered traditional screening paradigms. This executive summary distills the key findings, technological advancements, and strategic considerations that define the current landscape of AI-powered breast cancer detection. By framing the discussion around pivotal industry trends and stakeholder needs, it sets the stage for informed decision making and forward-looking investments in diagnostic innovation.

Unveiling paradigm shifts reshaping breast cancer screening with AI-infused imaging modalities, tomosynthesis maturation, and dynamic regulatory frameworks

Over the past decade, transformative technological shifts have redefined how clinicians approach breast cancer detection. The integration of AI-powered analytic engines into digital mammography platforms has elevated lesion characterization beyond human capabilities, while the maturation of three-dimensional tomosynthesis techniques has provided unprecedented depth resolution and diagnostic clarity.

Simultaneously, advancements in MRI protocols-particularly diffusion-weighted imaging and dynamic contrast-enhanced sequences-have been augmented by sophisticated AI algorithms that enhance tumor delineation. These parallel developments are complemented by the emergence of automated ultrasound solutions that deliver rapid, reproducible assessments. As regulatory bodies adapt to assess complex machine learning models, and reimbursement mechanisms evolve to reward value-based outcomes, organizations are compelled to adopt agile strategies that harness these innovations for superior patient care.

Assessing the compounding effects of 2025 US tariffs on breast cancer detection technologies, supply chain dynamics, and global market competitiveness

In 2025, the introduction of targeted tariffs by the United States on imported imaging hardware and related components has had a compounding impact on the breast cancer CAD ecosystem. Equipment manufacturers face increased input costs for servers, workstations and specialized imaging sensors, driving a strategic pivot toward domestic sourcing and localized supply chains.

These trade measures have not only influenced capital expenditure patterns for healthcare providers but also reshaped pricing negotiations and procurement timelines. As vendors adjust their go-to-market strategies to mitigate the effect of higher duties, organizations must proactively reassess vendor contracts, evaluate total cost of ownership across deployment models, and explore hybrid onshore-offshore solutions that balance cost, compliance, and innovation velocity.

Revealing segmentation-driven insights into breast cancer CAD across modality, technology, deployment models, end-user environments, applications and components

A granular examination of market segmentation reveals critical nuances that inform product development and deployment strategies. Within imaging modalities, analog and digital mammography platforms coexist alongside growing adoption of synthetic two-dimensional and three-dimensional tomosynthesis, while advanced MRI techniques such as diffusion-weighted imaging and dynamic contrast-enhanced protocols gain traction. Automated ultrasound platforms compete with handheld units, reflecting divergent preferences across clinical settings.

Algorithmically, deep learning architectures-spanning convolutional neural networks and recurrent neural networks-are increasingly favored over traditional rule-based systems, although random forest and support vector machine methods continue to serve niche diagnostic tasks. Deployment preferences oscillate between cloud-based private and public environments and on-premise integrated or standalone systems. In parallel, end users ranging from mobile outpatient clinics to large academic hospitals require tailored solutions, and the balance between diagnostic applications and mass screening initiatives dictates differing requirements for hardware, maintenance services, training programs, and advanced software capabilities in image processing and visualization.

Analyzing regional variations in breast cancer CAD adoption and growth drivers across Americas, EMEA and Asia-Pacific to uncover strategic market dynamics

Regionally, the Americas have emerged as a frontrunner in adopting AI-powered CAD, propelled by robust reimbursement frameworks, high awareness of screening guidelines and extensive clinical validation efforts. Leading healthcare systems in North America leverage public and private cloud deployments to scale across outpatient clinics and hospital networks, while Latin American markets demonstrate cautious uptake influenced by infrastructure variability.

Across Europe, Middle East and Africa, regulatory convergence efforts such as CE marking harmonization have streamlined market entry, yet adoption rates vary by country due to differences in screening program maturity and physician training. By contrast, the Asia-Pacific region is witnessing accelerating investment in national screening initiatives, stimulated by growing disease prevalence and government incentives. These markets prioritize cost-effective on-premise solutions, often favoring integrated systems in community hospitals but exploring cloud-based innovations in metropolitan centers.

Highlighting leading technology vendors and disruptive newcomers driving innovation in breast cancer CAD through strategic partnerships and product launches

The competitive landscape for breast cancer CAD is marked by established imaging giants and agile AI-focused newcomers. Incumbent vendors have bolstered their portfolios through the integration of tomosynthesis CAD modules and deep learning enhancements in digital mammography. Simultaneously, specialized software providers are forging partnerships with hospital networks to deploy cloud-native analytics platforms that deliver continuous algorithm updates and performance monitoring.

At the forefront of innovation, emerging companies are securing regulatory clearance for novel neural network-based tools and forging alliances with MRI players to extend AI capabilities into advanced imaging domains. Strategic collaborations between hardware manufacturers and software developers have accelerated time-to-market, while bundled service offerings that include maintenance and clinician training are redefining the value proposition. These dynamics underscore the importance of end-to-end solution strategies in sustaining competitive advantage.

Empowering industry leaders with targeted strategies to optimize AI integration, strengthen regulatory alignment, accelerate adoption in breast cancer screening

To navigate this complex landscape, organizations should prioritize investment in scalable deep learning frameworks that can adapt to evolving imaging modalities and regulatory requirements. Cultivating partnerships with leading academic centers and AI research institutions will ensure access to cutting-edge algorithms, while proactive engagement with payers can facilitate the development of value-based reimbursement models.

Moreover, deploying hybrid cloud-on-premise architectures enables flexible scaling and resilience amid tariff-driven supply constraints. Training radiologists and technologists on AI-augmented workflows is essential to maximize detection performance and gain clinical buy-in. Finally, standardizing validation protocols across end-user environments-from outpatient clinics to community hospitals-will build confidence in CAD efficacy and drive widespread adoption.

Unraveling a research methodology leveraging primary expert interviews, comprehensive secondary analysis, data triangulation and validation processes

This analysis was built upon a rigorous methodology combining extensive secondary research with in-depth primary interviews. Publicly available regulatory filings, published clinical studies and technology white papers formed the backbone of the secondary analysis, providing a broad view of market trends and technological capabilities.

Primary research included structured interviews with radiologists, imaging center administrators, vendor product managers and regulatory specialists to validate assumptions and gauge adoption challenges. Quantitative data points were triangulated across multiple sources to ensure consistency, while a dedicated quality assurance process reviewed the integrity of all compiled information. This multi-phase approach underpins the robustness and reliability of the insights presented.

Synthesizing critical insights into the evolving computer-aided detection landscape for breast cancer screening and charting a clear path forward for innovation

Bringing together technological advancements, market dynamics and stakeholder perspectives, this executive summary charts the trajectory of AI-driven computer-aided detection in breast cancer screening. The convergence of enhanced imaging modalities, sophisticated deep learning models and adaptive deployment strategies is redefining early detection capabilities and operational efficiencies.

Looking ahead, sustained innovation will hinge on collaborative ecosystems that bridge imaging vendors, clinical researchers and payers to deliver measurable improvements in patient outcomes. By aligning strategic investments with evidence-based validation and regulatory foresight, industry participants can shape a future where precision screening becomes universally accessible and profoundly impactful.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Modality
    • Mammography
      • Analog Mammography
      • Digital Mammography
    • Mri
      • Diffusion-Weighted Imaging
      • Dynamic Contrast-Enhanced
    • Tomosynthesis
      • Synthetic Two-Dimensional
      • Three-Dimensional Tomosynthesis
    • Ultrasound
      • Automated
      • Handheld
  • Technology
    • Deep Learning
      • Convolutional Neural Network
      • Recurrent Neural Network
    • Machine Learning
      • Random Forest
      • Support Vector Machine
    • Rule-Based Algorithms
  • Deployment
    • Cloud-Based
      • Private Cloud
      • Public Cloud
    • On-Premise
      • Integrated
      • Standalone
  • End User
    • Clinics
      • Mobile
      • Outpatient
    • Diagnostic Centers
      • Chain
      • Standalone
    • Hospitals
      • Academic
      • Community
  • Application
    • Diagnostic
    • Screening
  • Component
    • Hardware
      • Servers
      • Workstations
    • Services
      • Maintenance
      • Training
    • Software
      • Image Processing
      • Visualization
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Hologic, Inc.
  • GE Healthcare Inc.
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • iCAD, Inc.
  • Volpara Health Technologies Limited
  • ScreenPoint Medical B.V.
  • Lunit Inc.
  • Kheiron Medical Technologies Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms for enhanced tumor characterization in mammography
5.2. Adoption of 3D breast tomosynthesis combined with computer-aided detection to reduce recall rates and false positives
5.3. Development of deep learning-powered imaging platforms for automated screening and risk stratification in dense breast tissues
5.4. Implementation of cloud-based computer-aided detection solutions to facilitate remote second-read reviews in telemammography workflows
5.5. Regulatory approvals of novel AI-driven detection software expanding coverage in emerging markets and non-western healthcare systems
5.6. Research on multimodal data fusion combining ultrasound, MRI, and digital mammography images for comprehensive breast cancer diagnosis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Computer-aided Detection for Breast Cancer Screening Market, by Modality
8.1. Introduction
8.2. Mammography
8.2.1. Analog Mammography
8.2.2. Digital Mammography
8.3. Mri
8.3.1. Diffusion-Weighted Imaging
8.3.2. Dynamic Contrast-Enhanced
8.4. Tomosynthesis
8.4.1. Synthetic Two-Dimensional
8.4.2. Three-Dimensional Tomosynthesis
8.5. Ultrasound
8.5.1. Automated
8.5.2. Handheld
9. Computer-aided Detection for Breast Cancer Screening Market, by Technology
9.1. Introduction
9.2. Deep Learning
9.2.1. Convolutional Neural Network
9.2.2. Recurrent Neural Network
9.3. Machine Learning
9.3.1. Random Forest
9.3.2. Support Vector Machine
9.4. Rule-Based Algorithms
10. Computer-aided Detection for Breast Cancer Screening Market, by Deployment
10.1. Introduction
10.2. Cloud-Based
10.2.1. Private Cloud
10.2.2. Public Cloud
10.3. On-Premise
10.3.1. Integrated
10.3.2. Standalone
11. Computer-aided Detection for Breast Cancer Screening Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Mobile
11.2.2. Outpatient
11.3. Diagnostic Centers
11.3.1. Chain
11.3.2. Standalone
11.4. Hospitals
11.4.1. Academic
11.4.2. Community
12. Computer-aided Detection for Breast Cancer Screening Market, by Application
12.1. Introduction
12.2. Diagnostic
12.3. Screening
13. Computer-aided Detection for Breast Cancer Screening Market, by Component
13.1. Introduction
13.2. Hardware
13.2.1. Servers
13.2.2. Workstations
13.3. Services
13.3.1. Maintenance
13.3.2. Training
13.4. Software
13.4.1. Image Processing
13.4.2. Visualization
14. Americas Computer-aided Detection for Breast Cancer Screening Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Computer-aided Detection for Breast Cancer Screening Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Computer-aided Detection for Breast Cancer Screening Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Hologic, Inc.
17.3.2. GE Healthcare Inc.
17.3.3. Siemens Healthineers AG
17.3.4. Fujifilm Holdings Corporation
17.3.5. Canon Medical Systems Corporation
17.3.6. iCAD, Inc.
17.3.7. Volpara Health Technologies Limited
17.3.8. ScreenPoint Medical B.V.
17.3.9. Lunit Inc.
17.3.10. Kheiron Medical Technologies Ltd.
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET: RESEARCHAI
FIGURE 28. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 29. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET: RESEARCHCONTACTS
FIGURE 30. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIFFUSION-WEIGHTED IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIFFUSION-WEIGHTED IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DYNAMIC CONTRAST-ENHANCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DYNAMIC CONTRAST-ENHANCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SYNTHETIC TWO-DIMENSIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SYNTHETIC TWO-DIMENSIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY THREE-DIMENSIONAL TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY THREE-DIMENSIONAL TOMOSYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY RANDOM FOREST, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY RANDOM FOREST, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SUPPORT VECTOR MACHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SUPPORT VECTOR MACHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY RULE-BASED ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY RULE-BASED ALGORITHMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY INTEGRATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STANDALONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MOBILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STANDALONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMMUNITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMMUNITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY WORKSTATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY VISUALIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY VISUALIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 223. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 224. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 225. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 226. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 227. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 228. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 229. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2018-2024 (USD MILLION)
TABLE 230. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TOMOSYNTHESIS, 2025-2030 (USD MILLION)
TABLE 231. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 232. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 233. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 236. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 237. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 238. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 239. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 240. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 241. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2018-2024 (USD MILLION)
TABLE 242. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD-BASED, 2025-2030 (USD MILLION)
TABLE 243. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 244. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 245. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 250. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 251. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. CANADA COMPUTER-AIDED DETECTION FOR BREAST CANCER SCREENING MARKET SIZE, BY COMPONENT, 2018-2024 (

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Computer-aided Detection for Breast Cancer Screening Market report include:
  • Hologic, Inc.
  • GE Healthcare Inc.
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • iCAD, Inc.
  • Volpara Health Technologies Limited
  • ScreenPoint Medical B.V.
  • Lunit Inc.
  • Kheiron Medical Technologies Ltd.

Related Topics

Related Reports

Computer-Aided Detection Global Market Report 2025 - Product Image

Computer-Aided Detection Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Computer Aided Detection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Computer Aided Detection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Computer Aided Detection Market - Global Forecast 2025-2030 - Product Image

Computer Aided Detection Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Computer Aided Detection (CAD) - Global Strategic Business Report - Product Image

Computer Aided Detection (CAD) - Global Strategic Business Report

  • Report
  • 203 Pages
  • Global
From
Breast Intelligent Analysis System Market - Global Forecast 2025-2030 - Product Image

Breast Intelligent Analysis System Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.